Clarius Awarded Technology Breakthrough Designation in Ultrasound Category with Premier, Inc.

Clarius Mobile Health has been awarded a Technology Breakthrough Designation in the Ultrasound contract category with Premier, Inc. Effective December 1, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Clarius technology.

Premier offers Breakthrough Technology designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes, and operational efficiencies. Clarius proved to provide these benefits to Premier members with their broad range of specialty-focused ultrasound scanners, market-leading AI applications, and best-in-class image quality.

“Being awarded Premier’s Technology Breakthrough is an important step towards achieving our mission to put accurate, easy-to-use, and affordable ultrasound into the hands of every clinician,” says Clarius President and Chief Executive Officer Ohad Arazi. “Point-of-care ultrasound is a critical tool for achieving the quadruple aim in healthcare and Clarius is the ideal portable device for rapid diagnoses and safe ultrasound-guided treatments. We look forward to supporting Premier members in providing the best patient experience, improving health outcomes, enhancing clinician satisfaction, and ultimately reducing healthcare costs.”

Powered by artificial intelligence and designed to work wirelessly with current iOS and Android devices, Clarius has miniaturized diagnostic quality ultrasound to the size of a smartphone for ultra portability from patient to patient throughout the hospital. Only Clarius offers a comprehensive line of wireless scanners and advanced specialty packages designed to deliver superior imaging for an extensive range of clinical applications.

  • For emergency medicine, critical care, anesthesia, internal medicine, and nursing, the Clarius PAL HD3 dual-array (phased plus linear) scanner delivers high-resolution imaging of superficial and deep anatomy delivering versatile whole-body imaging.
  • For obstetrics and gynecology, labor and delivery, and urology, the Clarius C3 HD3 convex and Clarius EC7 HD3 endocavity scanners offer a complete ultraportable solution.
  • For physiatry, orthopedic surgery, pain management, and rheumatology, clinicians can choose from three linear scanners, the Clarius L15 HD3, Clarius L7 HD3, and Clarius L20 HD3, with the Clarius C3 HD3 convex for deeper hip and spine imaging.
  • For pediatric ultrasound, the Clarius C7 HD3 offers high-resolution, high frame rate imaging clearly down to 18 cm.

“In addition to the actual quality of the image, you’re getting it wirelessly. It’s on par with any corded device I have,” says orthopaedic surgeon Dr. Alan Hirahara. “For me, being able to bring it into the operating room and pop it into a bag that’s sterile is so much better than having a cord that could be prone to contaminating the surgical field. And you can place your monitor anywhere because you’re not tethered by a cord.”

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,300 U.S. hospitals and 300,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”